Clinical Trials in Los Angeles

Showing 15161-15180 of 16,901 trials

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

NCT00828594

Phase 1 Evaluate the safety and tolerability of RAD001 in combination with sorafenib in patients with advance hepatocellular cancer (HCC) and to determine the maximum tolerated dose (MTD) Phase 2 To estimate the treatment effect as a measure of anti-tumor activity in terms of Time to Progression (TTP) of the combination of RAD001 plus sorafenib, at the MTD, as compared to sorafenib alone

Hepatocellular Carcinoma

Novartis Pharmaceuticals130 participantsStarted Dec 2008

Duarte, California, United States • Los Angeles, California, United States • Durham, North Carolina, United States +5 more locations

TERMINATEDPhase 2< 1 mile

Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

NCT00003386

RATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV ovarian epithelial cancer.

Ovarian Cancer

Gynecologic Oncology GroupStarted Jul 1999

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +57 more locations

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Find Trials by Condition in Los Angeles

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis

rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Biological Therapy in Treating Patients With Prostate Cancer

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Secondary Prevention of Small Subcortical Strokes Trial

MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis

Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

PinPointe FootLaser for the Treatment of Onychomycosis